VIDEO Johnson and Johnson to Enroll 60000 Volunteers for COVID 19 Vaccine Candidate

feature image
Johnson & Johnson just announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate where it will look to enroll up to 60,000 volunteers across three continents.
Related tags: epidemic stocks djia equities
Open an account today

Experience award-winning platforms with fast and secure execution.

Economic Calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.